Home       Company       Products       Investors       Contact Us  
 
 
About Us Leadership Board Technology Advisory Board  

Jonathan M. Rigby, CEO
Jonathan has over 20 years commercial experience in the pharmaceutical, medical device and drug delivery industry. He started his career in large pharma with Merck and Bristol Myers Squibb before focusing his career on Drug Delivery and Specialty Pharmaceuticals.  In 2006, Jonathan Co-Founded Zogenix Inc. (NASDAQ - ZGNX) and as an Officer of the company played a key role in raising over $250 Million in venture capital and a successful IPO. Jonathan was also a part of the team at Zogenix that developed and launched, in the U.S. and EU, the worlds first and only prefilled, disposable, needle free, drug delivery injection system which was regulated and approved as a drug product for the treatment of acute migraine.

Keren Fradkin, VP R&D and General Manager SteadyMed Ltd
Dr. Fradkin has 18 years of experience in executive R&D positions and development of multidisciplinary systems in the medical devices, communications and semiconductors industries. Among these companies are Ophthalmic Imaging Systems (formerly MediVision Medical Imaging Ltd., recently acquired by Merge Healthcare), Negevtech Ltd. and ZettaLight Inc., of which she was a Co-Founder. She served as an officer in the elite technology unit of the Intelligence Corps, IDF. Dr. Fradkin holds a BSc in Physics and a PhD in Physical Electronics (Summa cum Laude) from Tel Aviv University.

 


Ian Solomon, VP Business Development

Ian Solomon is a successful serial entrepreneur who has led the commercialization of several innovations in the drug-packaging and biotech fields, leading to licensing arrangements and three “exits”.  Since 2003 he has concentrated on start-up ventures in the drug-delivery and dispensing field, and specialized in IP strategy in this field.  

Gidi Kahana, VP Technology, Electrochemistry
Co-founder of SteadyMed Ltd. and an experienced manager, Gidi Kahana has a background in chemistry, electrochemistry and life sciences.  Previously, he served as Managing Director of Novobiotec Ltd., a drug-delivery company specializing in delivering live probiotic bacteria, prior to its sale to a public US corporation.  Prior to that, Mr. Kahana spent 12 years as Managing Director of Satec Ecochem Ltd., a company specializing in electrochemistry and chemical production.

Ella Tenenbaum-Koren MD, MBA, VP Drug Product Development
Dr. Tenenbaum-Koren has over 25 years experience in the medical, pharmaceutical and medical device industry. She started her career with Agis (Currently Perigo Co) as its Medical Director and in 1998 she joined Pfizer and was among the founders of Pfizer Israel. She established Pfizer Israel’s Medical Department and served as the Pfizer Israel Medical Director for nearly 10 years. In this role she managed a team of medical experts responsible for clinical trials, regulatory and medical affairs and pharmacovigilance in close collaboration with sales, marketing and business development. She has broad experience in the healthcare and life science arena and vast experience in collaboration with its major stake holders – HMOs, academia, physician associations, Ministry of Health, life science industry, VCs, major medical centers and key opinion leaders. Dr. Tenenbaum-Koren also operates a consultancy company specializing in medical strategy and business development. Dr. Tenenbaum-Koren holds M.D. and MBA (majoring in marketing) degrees both from the Tel Aviv University.

Alexander Rodkin, PhD, Senior Researcher
Dr. Rodkin has 18 years R&D experience as a Senior Researcher in Electrochemistry. In his last position he was Head of the Electrode laboratory at More Energy, Ltd. previously he was a Senior Researcher in the Electrochemistry group at Bar-Ilan University. Dr. Rodkin holds a PhD in Chemistry from the Institute of Physical Chemistry, Moscow.

 


 
            The SteadyMed devices are not yet approved for sale.